[go: up one dir, main page]

WO2001000083A8 - Systeme de simulation virtuelle du cancer humain - Google Patents

Systeme de simulation virtuelle du cancer humain

Info

Publication number
WO2001000083A8
WO2001000083A8 PCT/US2000/017810 US0017810W WO0100083A8 WO 2001000083 A8 WO2001000083 A8 WO 2001000083A8 US 0017810 W US0017810 W US 0017810W WO 0100083 A8 WO0100083 A8 WO 0100083A8
Authority
WO
WIPO (PCT)
Prior art keywords
cancer
information
human cancer
metastases
series
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/017810
Other languages
English (en)
Other versions
WO2001000083A9 (fr
WO2001000083A1 (fr
Inventor
Richard D Thomas
Sterling Thomas
John F Meagher
Austin W Thomas
Joel Thomas
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
INTERCET Ltd
Original Assignee
INTERCET Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by INTERCET Ltd filed Critical INTERCET Ltd
Priority to EP00944968A priority Critical patent/EP1198195A1/fr
Priority to AU58976/00A priority patent/AU5897600A/en
Priority to JP2001505803A priority patent/JP2003503770A/ja
Priority to CA002376831A priority patent/CA2376831A1/fr
Publication of WO2001000083A1 publication Critical patent/WO2001000083A1/fr
Anticipated expiration legal-status Critical
Publication of WO2001000083A8 publication Critical patent/WO2001000083A8/fr
Publication of WO2001000083A9 publication Critical patent/WO2001000083A9/fr
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16HHEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/50ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for simulation or modelling of medical disorders
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
    • G16B20/20Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
    • GPHYSICS
    • G16INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16BBIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B20/00ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Evolutionary Biology (AREA)
  • Analytical Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Theoretical Computer Science (AREA)
  • Public Health (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Primary Health Care (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)

Abstract

Une série d'algorithmes mathématiques et de processus descriptifs mettent en application des informations obtenues par la biologie moléculaire et la science médicale afin de simuler l'apparition et les métastases du cancer dans le corps humain. Le moteur de cette simulation virtuelle du cancer humain ou HCVS consiste en une série de modules (5) de programmes logiciels exécutés sur un ordinateur et contenant les informations médicales nécessaires à une simulation de l'apparition et des métastases du cancer dans le corps humain. Ces programmes permettent d'intégrer des renseignements individuels (2) concernant le patient et entrés par l'utilisateur, de manière à obtenir des résultats de données sous forme de rapports statistiques et prédictifs, ainsi que des lignes temporelles applicables dans le futur ou le passé. Cette configuration permet de sélectionner des modules, des paramètres de sous-programmes et des renseignements (2) concernant le patient, de manière à les entrer sélectivement dans le moteur. L'utilisateur (3) a la possibilité, en fonction de la sélection, de se déplacer en avant et en arrière dans le temps afin de générer des résultats simulés concernant le cancer humain, tels que, par exemple, des informations biologiques.
PCT/US2000/017810 1999-06-29 2000-06-29 Systeme de simulation virtuelle du cancer humain Ceased WO2001000083A1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
EP00944968A EP1198195A1 (fr) 1999-06-29 2000-06-29 Systeme de simulation virtuelle du cancer humain
AU58976/00A AU5897600A (en) 1999-06-29 2000-06-29 Human cancer virtual simulation system
JP2001505803A JP2003503770A (ja) 1999-06-29 2000-06-29 ヒト癌仮想シミュレーション装置
CA002376831A CA2376831A1 (fr) 1999-06-29 2000-06-29 Systeme de simulation virtuelle du cancer humain

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14100699P 1999-06-29 1999-06-29
US60/141,006 1999-06-29

Publications (3)

Publication Number Publication Date
WO2001000083A1 WO2001000083A1 (fr) 2001-01-04
WO2001000083A8 true WO2001000083A8 (fr) 2002-01-24
WO2001000083A9 WO2001000083A9 (fr) 2002-09-06

Family

ID=22493735

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/017810 Ceased WO2001000083A1 (fr) 1999-06-29 2000-06-29 Systeme de simulation virtuelle du cancer humain

Country Status (5)

Country Link
EP (1) EP1198195A1 (fr)
JP (1) JP2003503770A (fr)
AU (1) AU5897600A (fr)
CA (1) CA2376831A1 (fr)
WO (1) WO2001000083A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60117555T2 (de) 2001-07-23 2007-01-11 F. Hoffmann-La Roche Ag Bewertungssystem für die vorhersage von krebsrezidiven
WO2004025393A2 (fr) 2002-09-16 2004-03-25 Optimata, Ltd. Technique interactive d'optimisation de la mise au point de medicaments a partir de phases precliniques passant par la phase iv
US8489336B2 (en) 2002-09-16 2013-07-16 Optimata Ltd. Techniques for purposing a new compound and for re-purposing a drug
JP2006309465A (ja) * 2005-04-27 2006-11-09 Sense It Smart Corp 歯科健康管理システム、口腔内情報解析装置、歯科疾患解析方法、及びプログラム
CN102084366A (zh) * 2008-05-12 2011-06-01 皇家飞利浦电子股份有限公司 医学分析系统
KR101224472B1 (ko) 2011-02-24 2013-01-24 서강대학교산학협력단 암세포 거동 모델링 방법 및 장치
KR101224179B1 (ko) 2011-02-24 2013-01-21 서강대학교산학협력단 유영세포의 거동 모델링 방법 및 장치
KR101224180B1 (ko) 2011-02-24 2013-01-21 서강대학교산학협력단 흡착세포의 거동 모델링 방법 및 장치
US9662064B2 (en) * 2011-10-01 2017-05-30 Brainlab Ag Automatic treatment planning method using retrospective patient data
CN105210083B (zh) * 2013-03-15 2019-05-21 霍罗杰克股份有限公司 用于查验和分析细胞学标本的系统和方法
CN116640847A (zh) 2016-02-02 2023-08-25 夸登特健康公司 癌症进化检测和诊断
CN107126193B (zh) * 2017-04-20 2020-02-28 杭州电子科技大学 基于滞后阶数自适应选择的多变量因果关系分析方法
EP3591666A1 (fr) * 2018-07-04 2020-01-08 Dassault Systèmes Simulation de l'évolution d'une tumeur

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5790761A (en) * 1992-12-11 1998-08-04 Heseltine; Gary L. Method and apparatus for the diagnosis of colorectal cancer
US5594637A (en) * 1993-05-26 1997-01-14 Base Ten Systems, Inc. System and method for assessing medical risk
US5517405A (en) * 1993-10-14 1996-05-14 Aetna Life And Casualty Company Expert system for providing interactive assistance in solving problems such as health care management
ZA948393B (en) * 1993-11-01 1995-06-26 Polartechnics Ltd Method and apparatus for tissue type recognition
CA2125300C (fr) * 1994-05-11 1999-10-12 Douglas J. Ballantyne Methode et dispositif pour la distribution electronique d'information medicale et de services aux patients
EP0846296A1 (fr) * 1995-03-31 1998-06-10 Richard I. Levin Systeme et method d'etablissement de rapport de controle de l'etat de sante des coronaires
US5756294A (en) * 1995-09-25 1998-05-26 Oncormed, Inc. Susceptibility mutation for breast and ovarian cancer
US5794208A (en) * 1996-03-01 1998-08-11 Goltra; Peter S. Creating and using protocols to create and review a patient chart
US5858683A (en) * 1996-08-30 1999-01-12 Matritech, Inc. Methods and compositions for the detection of cervical cancer

Also Published As

Publication number Publication date
JP2003503770A (ja) 2003-01-28
EP1198195A1 (fr) 2002-04-24
CA2376831A1 (fr) 2001-01-04
AU5897600A (en) 2001-01-31
WO2001000083A9 (fr) 2002-09-06
WO2001000083A1 (fr) 2001-01-04

Similar Documents

Publication Publication Date Title
WO2001000083A8 (fr) Systeme de simulation virtuelle du cancer humain
ATE202914T1 (de) Verfahren und anordnung mit einem artikulator sowie einer datenverarbeitungsanlage
WO2004068406A3 (fr) Procede et systeme de traitement d'image et d'evaluation de contour
US5657255C1 (en) Hierarchic biological modelling system and method
GB2343273A (en) System and method for optimizing behavioral health care data collection
WO2000055751A8 (fr) Systeme d'etablissement automatique de profils permettant de fournir des informations medicales a des patients
EP1396802A3 (fr) Procédé et système pour assister la construction
WO2004070553A3 (fr) Systeme et procede permettant de faciliter une intervention cardiaque
WO2003023682A3 (fr) Modelisation de systemes metaboliques
Çavuşoğlu et al. GiPSi: An Open Source/Open Architecture
Kurzweil Human life: The next generation
Koch et al. Agency in co-creativity: Towards a structured analysis of a concept
Schiphorst et al. Using a gestural interface toolkit for tactile input to a dynamic virtual space
Yildirim et al. 34 Physical Object Repre sen ta tions for Perception and Cognition
WO2002037398A3 (fr) Systèmes, procédés et progiciels d'assistance dans le choix d'un schéma posologique tenant compte de l'état de méthylation de l'adn
EP1434156A3 (fr) Procédé pour mener une étude clinique
Fleisher Computational Immunology and its Applications
Marmarelis et al. LYSIS: An interactive software system for non-linear modeling and simulation.
Varkonyi et al. A calculator package for pharmacokinetic application
Gani Cooperation and Conflict in General Evolutionary Processes.
Perwitasari Evaluasi Usability Aplikasi HOVAR: Marker-Based Tracking AR untuk Visualisasi Anatomi Organ Tubuh Manusia Berbasis Android
Kemeny et al. The Dartmouth Time-Sharing Computing System. Final Report.
Bishop et al. The use of a virtual integration environment for the real-time implementation of neural decode algorithms
Slade Definitive parallel programming
Feigenbaum A Marx-Freud Dialogue?

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2376831

Country of ref document: CA

Ref country code: CA

Ref document number: 2376831

Kind code of ref document: A

Format of ref document f/p: F

AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i
WWE Wipo information: entry into national phase

Ref document number: 2000944968

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2000944968

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 10009462

Country of ref document: US

COP Corrected version of pamphlet

Free format text: PAGES 1-36, DESCRIPTION, REPLACED BY NEW PAGES 1-35; PAGES 37-38, CLAIMS, REPLACED BY NEW PAGES 36-37; PAGES 1/14-14/14, DRAWINGS, REPLACED BY NEW PAGES 1/17-17/17; DUE TO LATE TRANSMITTAL BY THE RECEIVING OFFICE

WWW Wipo information: withdrawn in national office

Ref document number: 2000944968

Country of ref document: EP